Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
To date, they represent the only G protein-coupled receptor (GPCR) ligands approved as glucose-lowering agents (2)
GLP-1 medications get at the heart of addiction: study Diabetes and obesity drugs show promise in treating and preventing all substance use disorders Sara Moser / WashU Medicine Researchers at Washington University School of Medicine in St
Park, S., Albert, D
By following best practices for storage and disposal, you can ensure that youre getting the most out of your supplements
68,00 AOD-9604 - Fat Metabolism & Weight Regulation Peptide Aids in the metabolic process of accelerating stored fatty acid breakdown into usable energy Supports the suppression of new fat cell formation in adipose tissue Observed to avoid negative impact on glucose tolerance or insulin sensitivity Delivers metabolic support without increasing IGF-1 levels or causing systemic growth effects Showed high tolerability in human trials, comparable to placebo Clinical studies indicated no anti-AOD-9604 antibodies were detected Preclinical research suggests potential for promoting repair and regeneration in joint models Research indicates potential for lowering cholesterol and triglycerides in metabolic studies Description AOD-9604 is a synthetic fragment of human growth hormone (HGH 177-191) designed to selectively enhance fat metabolism without influencing growth-promoting or insulin-modulating pathways
Published January 12, 2024
